Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127893641 | 12789364 | 1 | I | 20160926 | 20160928 | 20160928 | EXP | GB-MHRA-EYC 00145559 | GB-DRREDDYS-GER/UKI/16/0083634 | DR REDDYS | 61.00 | YR | M | Y | 0.00000 | 20160928 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127893641 | 12789364 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Oral | U | U | UNKNOWN | 91650 | 80 | MG | QD | |||||
127893641 | 12789364 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | U | 0 | 2.5 | MG | ||||||||
127893641 | 12789364 | 3 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | U | U | 0 | 2.5 | MG | BID | ||||||
127893641 | 12789364 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
127893641 | 12789364 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
127893641 | 12789364 | 6 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | 0 | ||||||||||||
127893641 | 12789364 | 7 | C | NICOTINE TRANSDERMAL SYSTEM | NICOTINE | 1 | 0 | ||||||||||||
127893641 | 12789364 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
127893641 | 12789364 | 9 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127893641 | 12789364 | 10 | C | TICAGRELOR | TICAGRELOR | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127893641 | 12789364 | 1 | Product used for unknown indication |
127893641 | 12789364 | 2 | Product used for unknown indication |
127893641 | 12789364 | 3 | Product used for unknown indication |
127893641 | 12789364 | 4 | Product used for unknown indication |
127893641 | 12789364 | 5 | Product used for unknown indication |
127893641 | 12789364 | 6 | Product used for unknown indication |
127893641 | 12789364 | 7 | Product used for unknown indication |
127893641 | 12789364 | 8 | Product used for unknown indication |
127893641 | 12789364 | 9 | Product used for unknown indication |
127893641 | 12789364 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127893641 | 12789364 | HO |
127893641 | 12789364 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127893641 | 12789364 | Bradycardia | |
127893641 | 12789364 | Circulatory collapse | |
127893641 | 12789364 | Liver function test abnormal | |
127893641 | 12789364 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127893641 | 12789364 | 4 | 201606 | 0 |